Riskpilot← Back to searchSign inGet full accessTRYSILTANNLEGENE AS
ASActiveOrg 824689512Løkjavegen 1, 2420 TrysilDental practice care activities · NACE 8623Est. 20205 employees
Revenue 2024
NOK 9,3M
+5% vs 2023
EBITDA margin
23.5%
-17% vs 2023
Equity ratio
22.6%
Financial strength
Net profit 2024
NOK 1,3M
-23% vs 2023
| Revenue | NOK 9,3M | +5% |
| EBITDA | NOK 2,2M | -17% |
| Net profit | NOK 1,3M | -23% |
| Total assets | NOK 6,5M | +0% |
| Equity | NOK 1,5M | -34% |
| Employees | 5 | — |
Legal name
TRYSILTANNLEGENE AS
Org number
824689512
Legal form
Aksjeselskap
NACE code
8623 · Dental practice care activities
Founded
2. mars 2020
Share capital
NOK 500 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Selge tjenester og varer innen tannlege - og annet som naturlig sammenfaller med dette - samt deltakelse i andre selskaper, investeringer og nærliggende virksomhet.
Address
Løkjavegen 1, 2420 Trysil
Phone
+4797330503
Email
kontakt@trysiltannlegene.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 517 | 6 008 | 7 506 | 8 863 | 9 319 |
| Staff expenses | −709 | −2 211 | −2 213 | −2 339 | −2 846 |
| EBITDA | 800 | 1 247 | 1 750 | 2 649 | 2 187 |
| Depreciation & amort. | −91 | −206 | −237 | −238 | −258 |
| EBIT | 709 | 1 041 | 1 513 | 2 411 | 1 930 |
| Net financials | −82 | −132 | −149 | −207 | −224 |
| Profit before tax | 627 | 909 | 1 364 | 2 205 | 1 706 |
| Tax | 138 | 200 | 300 | 485 | 376 |
| Net profit | 489 | 709 | 1 064 | 1 719 | 1 330 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 5 253 | 5 707 | 6 888 | 6 488 | 6 499 |
| Equity | 989 | 1 434 | 898 | 2 219 | 1 471 |
| Long-term debt | 3 701 | 3 452 | 3 187 | 2 924 | 2 667 |
| Short-term debt | 563 | 821 | 2 803 | 1 344 | 2 361 |
| Total debt | 4 264 | 4 273 | 5 990 | 4 268 | 5 028 |
EBITDA margin
23.5%
This company
15.8%
Market median
+49% vs market
20202024
Equity ratio
22.6%
This company
38.2%
Market median
-41% vs market
20202024
Return on equity
90.4%
This company
18.4%
Market median
+391% vs market
20202024
Net profit margin
14.3%
This company
8.1%
Market median
+77% vs market
20202024
Asset turnover
1.43×
This company
1.12×
Market median
+28% vs market
20202024
Debt / equity
3.42×
This company
0.62×
Market median
-452% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-25 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RD Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TRYSILTANNLEGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roza Denize Arazi Yazdani | Chief Executive Officer | 0 companies |
| Terje Sæthre | Board of Directors | 0 companies |